Financing, Equity Capital Markets

Catalyst Biosciences, Inc.

01/21
|
$52.8 Million
Piper Sandler served as bookrunner for Catalyst Biosciences, Inc. on a confidentially marketed follow-on offering
Sub-Type
CMFO
Sub-Sector
Biopharma